Author:
Aletaha Daniel,Smolen Josef S.
Reference63 articles.
1. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials: The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials;Felson;Arthritis Rheum,1993
2. The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT);Smolen;Br J Rheumatol,1992
3. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials;Boers;J Rheumatol Suppl,1994
4. A proposed 30–45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes;Pincus;J Rheumatol,1999
5. The disablement process in rheumatoid arthritis;Escalante;Arthritis Rheum,2002
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献